Monoclonal Antibody Therapy for COVID-19: Webinar Recording & Access


The federal government now allows eligible licensed pharmacists to order and administer COVID-19 therapeutics that Food and Drug Administration (FDA) has approved, authorized, cleared, or licensed. The amendment also authorizes pharmacy interns and pharmacy technicians to administer these COVID-19 therapeutics. This federal authority was made official when the U.S. Department of Health and Human Services (HHS) released its ninth amendment to the Public Readiness and Emergency Preparedness (PREP) Act on September 9, 2021.

In addition to vaccines and antivirals, monoclonal antibodies (mAb) are important treatment options against the virus that causes COVID-19 and are another service that can be offered by pharmacies. If you missed the first webinar, click here to fulfill the required training to comply with the PREP Act. This is the second webinar in the mAb series focused on ordering, reporting, billing, and best practices for implementing into the workflow. It is critical to design the workflow around an administration and monitoring location that keeps COVID-positive patients separated from others.

This is a non-accredited program.


Dr. Alexis Page
Virginia Department of Health
COVID-19 Pharmacy Coordinator

Dr. Stephanie Wheawill 
Virginia Department of Health
Director of Pharmacy Services

Dr. Eric Crumbaugh
Express Rx
Director of Clinical Business Development

Registration Rates

VPhA Member: FREE (Members MUST login to view content)
Non-Member: $10 (Non-Members should contact for access)

Click Here to Access Video